Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | -60 | 235 | 725 | 403 | 578 |
| Gross Profit | -60 | 235 | 725 | 403 | 926 |
| Operating Expenses | 11,499 | 10,132 | 7,543 | 7,131 | 8,332 |
| Operating Income | -11,559 | -9,897 | -6,819 | -6,729 | -7,754 |
| Other Income | -70 | 115 | 248 | 329 | 385 |
| Pre-tax Income | -11,629 | -9,781 | -6,571 | -6,400 | -7,369 |
| Net Income Continuous | -8,658 | -7,787 | -5,426 | -5,064 | -6,947 |
| Net Income Discontinuous | N/A | 285 | -269 | -170 | -626 |
| Net Income | $-8,658 | $-7,502 | $-5,695 | $-5,234 | $-7,573 |
| EPS Basic Total Ops | -2.10 | -1.90 | -1.50 | -1.40 | -1.90 |
| EPS Basic Continuous Ops | -2.17 | -2.00 | -1.40 | -1.30 | -1.81 |
| EPS Basic Discontinuous Ops | 0.06 | 0.10 | -0.10 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -2.10 | -1.90 | -1.50 | -1.40 | -1.90 |
| EPS Diluted Continuous Ops | -2.17 | -2.00 | -1.40 | -1.30 | -1.81 |
| EPS Diluted Discontinuous Ops | 0.06 | 0.10 | -0.10 | -0.10 | -0.10 |
| EBITDA(a) | $-11,275 | $-9,630 | $-6,521 | $-6,443 | $-7,468 |